Association between patient medications and postoperative outcomes in early-stage non-small cell lung cancer.

ABSTRACT:

Background

Currently, there is no consensus on how to comprehensively assess comorbidities in lung cancer patients in the clinical setting. Prescription medications may be a preferred comorbidity assessment tool and provide a simple mechanism for predicting postoperative outcomes for lung cancer. We examined the relationship between prescription medications and postoperative outcomes for early-stage non-small cell lung cancer (NSCLC).

Methods

We conducted a retrospective cohort study of patients with clinical stage I NSCLC who underwent surgical resection in the Veterans Health Administration (VHA) between 10/01/2006 and 09/30/2016. Details of all outpatient prescriptions filled by patients within the VHA system from 1-year up to 14 days before surgery were collected. Medica

SUBMITTER: Tohmasi S 

PROVIDER: S-EPMC11565336 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature